Skeletal muscle regeneration results from the activation and differentiation of myogenic stem cells, called satellite cells, located beneath the basal lamina of the muscle fibers. Inflammatory and immune cells have a crucial role in the regeneration process. Acute muscle injury causes an immediate transient wave of neutrophils followed by a more persistent infiltration of M1 (proinflammatory) and M2 (anti-inflammatory/proregenerative) macrophages. New studies show that injured muscle is also infiltrated by a specialized population of regulatory T (Treg) cells, which control both the inflammatory response, by promoting the M1-to-M2 switch, and the activation of satellite cells. Treg cells accumulate in injured muscle in response to specific cytokines, such as IL-33, and promote muscle growth by releasing growth factors, such as amphiregulin. Muscle repair during aging is impaired due to reduced number of Treg cells and can be enhanced by IL-33 supplementation. Migration of Treg cells could also contribute to explain the effect of heterochronic parabiosis, whereby muscle regeneration of aged mice can be improved by a parabiotically linked young partners. In mdx dystrophin-deficient mice, a model of human Duchenne muscular dystrophy, muscle injury, and inflammation is mitigated by expansion of the Treg-cell population but exacerbated by Treg-cell depletion. These findings support the notion that immunological mechanisms are not only essential in the response to pathogenic microbes and tumor cells but also have a wider homeostatic role in tissue repair, and open new perspectives for boosting muscle growth in chronic muscle disease and during aging.
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Muscle regeneration
Skeletal muscle can regenerate following a variety of injuries, ranging from acute traumatic injuries, such as the strain injuries common in sport medicine, to chronic degenerative diseases, such as the muscular dystrophies, characterized by repeated cycles of segmental necrosis and regeneration [1] . Muscle regeneration can lead to complete restoration of the original structure, but often causes a remodeling of muscle structure: for example, forked or branched fibers are present in regenerated muscle, and the rupture of large myofiber bundles after strain injuries may lead to formation of scar tissue and new myotendinous junctions at the level of the rupture. In muscular dystrophies, the regenerative capacity becomes exhausted with time and fibrosis prevails, and a progressive decrease of the regeneration potential also occurs during aging. Ongoing research aims to identify pharmacological, gene-and cell-therapy approaches to boost muscle regeneration and thus rescue the muscle wasting associated with aging and neuromuscular diseases.
Muscle regeneration results from the activation and differentiation of myogenic stem cells, called satellite cells, located beneath the basal lamina of the muscle fibers [2, 3] . Upon activation, satellite cells exit from the quiescent state, defined by the expression of the paired box protein Pax7, and start to proliferate, with down-regulation of Pax7 and up-regulation of the muscle-specific transcription factors MyoD and myogenin. Activated satellite cells display both symmetric divisions to expand the satellite cell pool and asymmetric divisions to generate myogenic progenitors, which differentiate and fuse into multinucleated myofibers [4] . The newly formed muscle fibers initially express embryonic myosin heavy chain, which can be used as a specific marker of muscle regeneration [5] and are characterized by the presence of central, rather than peripheral nuclei (Fig. 1) . The regeneration process is controlled by an intrinsic program in muscle stem cells but can be modulated by extrinsic cues. Inflammatory and immune cells have a crucial role in the regeneration process [6] . Previous studies focused mostly on the role of macrophages but more recent investigations highlight the important contribution of other inflammatory cells, including eosinophils, and of regulatory T (Treg) cells to muscle regeneration.
Macrophages
The inflammatory reaction induced by acute muscle injury, characterized by a transient wave of neutrophils followed by a more persistent infiltration of macrophages, derived from circulating monocytes, is a condition for effective muscle regeneration. Muscle regeneration is impaired by macrophage depletion or by mutation of genes coding for chemokines responsible for monocyte recruitment from the blood [7, 8] . The primary function of macrophages in damaged muscle was initially associated with the clearance of necrotic muscle fibers and apoptotic leukocytes. However, two crucial observations revealed a more direct role of macrophages on myogenic cells. First, it was shown that myoblast proliferation and differentiation is enhanced in cocultures of macrophages and satellite cells as compared to purely myogenic cultures, and that this effect can be reproduced by adding macrophage-conditioned medium to muscle cell cultures [9, 10] . These findings suggested that macrophages infiltrating injured skeletal muscle are not only involved in the phagocytosis of necrotic fibers but may also release factors that promote muscle regeneration. Second, different populations of macrophages were identified in regenerating rat muscle [11] , and subsequent studies led to the identification of two macrophage populations, now referred to as M1 and M2 macrophages [12] . M1 macrophages appear soon after injury and rapidly decline, have a proinflammatory role, and stimulate satellite cell proliferation, while M2 macrophages have an anti-inflammatory role and promote myoblast fusion and myotube hypertrophy [7] . M1 and M2 macrophages are actually extremes in a continuum and it is not clear whether the activation of the M2 phenotype, often referred to as M2 'polarization', results from the transformation of M1 cells or reflects the existence of a distinct lineage [13, 14] . A number of studies in regenerating muscle have focused on the signals controlling the switching from M1 to M2 phenotype and the different types of cytokines that mediate their action [15] . However, specific markers defining unambiguously macrophage cell lineages are not available, therefore combinations of markers, or a lack of marker expression, are required to describe the macrophage phenotypes in the setting of tissue repair [14] .
Eosinophils and FAPs
Other inflammatory cell types, in addition to macrophages, appear to be involved in muscle regeneration. A recent study shows that interleukin (IL)-4 and IL-13 cytokines released by eosinophils are important for muscle regeneration, as both eosinophil-deficient mice and mice with knockout of Il4/Il13 genes show impaired muscle regeneration and reduced clearance of necrotic muscle fibers [16] . The proregenerative effect of IL-4 is not mediated via macrophages or myogenic precursors but via fibro-adipocyte progenitors (FAPs), a resident mesenchymal stem cell population characterized by a specific profile of cell-surface markers,
FAPs were shown to promote the differentiation of myogenic precursors into myofibers in coculture systems [17] . IL-4 induces proliferation of FAPs and inhibits their adipogenic differentiation, while stimulating the phagocytosis of necrotic cellular debris by these cells. However, following specific types of acute damage or in chronic muscle diseases, FAPs differentiate into fibroblasts and adipocytes, causing fibrosis and fatty infiltration [18, 19] .
Treg cells
T cells were also identified in dystrophic and injured skeletal muscle; however, their function was not established until recent studies focused on a specific population of Treg cells. Treg cells are CD4 + CD25 + T lymphocytes defined by the expression of forkhead box P3 (Foxp3), a lineage-specific transcription factor [20, 21] . These cells exert potent immunosuppressive actions, restricting immune responses to an array of microbial and nonmicrobial stimuli, and maintain immunological tolerance [22] . Congenital deficiency in Treg cells due to mutations of Foxp3 causes fatal autoimmunity in mice, the scurfy phenotype [23] , and the IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, Xlinked) in humans [24] .
Treg cells are normally present in lymphoid organs but accumulate in damaged tissues. Recent studies indicate that, aside from indirectly protecting tissues from collateral damages due to the inflammatory responses, Treg cells may promote tissue repair by acting directly on parenchymal cells [25] . Burzyn et al. [26] reported that a Treg-cell population, characterized by a specific T-cell receptor (TCR) repertoire and a gene expression profile distinct from that of Tregs present in lymphoid organs, accumulate in injured skeletal muscles, at the time when infiltrating myeloid-lineage cells switch from a proinflammatory to a proregenerative state (Fig. 1) . Interestingly, these 'muscle Tregs' represent a unique population that differs from those found in other tissues, such as visceral adipose tissue. Local factors released during muscle injury may be responsible for the differentiation of this Treg population. This interpretation would be consistent with the finding, based on the analysis of TCR repertoire, that a substantial proportion (around 30%) of muscle Tregs are clonally expanded, in contrast to splenic Tregs. The crucial observation supporting the role of Treg cells in the context of muscle injury is that muscle regeneration is compromised by conditional depletion of Tregs in a mouse line expressing a human diphtheria toxin receptor under control of Foxp3 regulatory elements [26] .
How do Treg cells affect muscle regeneration? As shown in Fig. 2 , Tregs not only promote the M1-to-M2 switch in macrophages but also directly act on muscle satellite cells [26] . Indeed, satellite cell proliferation is stimulated in vitro by cocultured activated Treg cells [27] . A specific growth factor, amphiregulin, also referred to as AREG, which is a ligand for epidermal growth factor receptor, is released by muscle Tregs and improves muscle regeneration by acting directly on satellite cells [26] . The importance of Treg-derived amphiregulin in promoting tissue repair and maintenance has been demonstrated in mice in which amphiregulin was specifically ablated in Treg cells [28] . After acute infection with influenza virus, these mice mount a normal antiviral T-cell response and clear the infection; however, they show altered lung function and repair. It will be of interest to perform similar loss-of-function experiments to confirm the role of amphiregulin in muscle regeneration.
What are the factors that induce the accumulation of Treg cells in injured muscle? A likely candidate is a cytokine, IL-33, which acts as an endogenous danger signal, or alarmin, in response to tissue damage and has been involved in the control of Treg cells in different tissues [29, 30] . IL-33 increases shortly after injury in skeletal muscle and acts on cells containing the ST2 (suppression of tumorigenicity 2) receptor, coded by the Il1rl1 (interleukin 1 receptor-like 1) gene. Il1rl1 is one of the more strongly up-regulated genes in Tregs isolated from injured muscle compared to Tregs present in lymphoid tissue [31] . Treg cells devoid of ST2, due to Treg cell-specific ablation of Il1rl1 gene, show impaired accumulation in injured muscle, less effective clearing of the muscle infiltrate and delayed muscle regeneration [31] . Cells expressing IL-33 have features resembling FAPs, as they express cell-surface markers typical of FAPs, and have a surprising distribution, being often associated with intramuscular nerve fibers and muscle spindles. IL-33 injection can increase the number of Tregs in different tissues within a few days and induce proliferation of Treg cells in culture [30, 32, 33] . However, the role of IL-33 in muscle regeneration has not yet been validated by loss-offunction experiments. In humans, the IL33 gene is apparently dispensable because individuals with IL33 knockout have no obvious health problems (see Data S2 in ref. [34] ). Other signals are probably implicated in Treg-cell accumulation, in particular among those with a characterized alarmin function. Labile heme, derived from myoglobin released by injured muscle fibers, is recognized by macrophages and possibly also by Treg cells, and might contribute to modulate the regenerative response [35] . The immune response induced by muscle injury can also be affected by ATP, released by necrotic muscle cells and by inflammatory cells, which is sensed as a danger-associated molecular pattern (DAMP) through P2 purinergic receptors (see below).
Treg cells in aging muscle
Muscle regeneration is known to be impaired in aged muscle due to intrinsic factors, namely a reduced number of functional stem cells, as shown by satellite cell transplantation studies, and environmental factors, as suggested by heterochronic parabiosis experiments [36, 37] . A recent study has addressed the role of Tregcell activation in muscle repair during aging [31] . The accumulation of Tregs is markedly decreased in injured muscles from aged mice, as a result of impaired recruitment, proliferation, and retention of Tregs in injured muscle. Treg cells of young and aged mice also show differences in the expression of genes encoding chemokine receptors [38] . These differences are apparently reversible because IL-33 supplementation was found to induce an increased Treg population and enhanced muscle regeneration in injured muscles of old mice [31] . These results reveal an additional mechanism that could contribute to the age-dependent impairment of muscle regeneration and suggest an alternative interpretation of heterochronic parabiosis experiments, in which the circulatory systems of young and old animals are joined (Fig. 3) . A seminal study by Tom Rando's laboratory showed that the impaired muscle regeneration in aged muscle can be reversed by heterochronic parabiosis and suggested that humoral factors from the young partner are responsible for this effect, a view supported by the finding that 'young serum' stimulates satellite cell proliferation and differentiation in vitro [39] . The serum factors present in the blood of young animals and responsible for the enhanced muscle regeneration have not yet been identified. The growth differentiation factor (GDF)-11, a member of the transforming growth factor (TGF)-b superfamily, was suggested to be a rejuvenating serum factor responsible for this effect [40] . However, a subsequent study showed that GDF11 levels increase rather than decrease during aging and that GDF11, like the closely related TGF-b member, myostatin, has an inhibitory rather than stimulatory effect on skeletal muscle regeneration [41] . The possibility that circulating stem cells could contribute to myogenic precursors in regenerating muscle was ruled out by the finding that, when aged GFP-negative mice were parabiosed to GFP-positive young partners, GFP-positive myonuclei in regenerating muscle fibers were extremely rare. On the other hand, GFP-positive cells were readily detected in the interstitial spaces of regenerating muscle, as a result of the blood chimerism between parabiosed partners [39, 42] . It is therefore likely that migrating Treg cells from the young partner infiltrate the injured muscle from the aged partner and contribute to promote muscle regeneration (Fig. 3) . The humoral vs cellular hypotheses are not necessarily incompatible, as both serum factors and Treg cells may be involved in this effect.
Treg cells in muscle disease
Treg cells were also detected in skeletal muscles of mdx dystrophin-deficient mice, a model of human Duchenne muscular dystrophy (DMD), in which muscle injury and inflammation is mitigated by expansion of the Treg population but exacerbated by Treg-cell depletion [26, 43] . It will be of interest to explore whether Treg-cell depletion contributes to the loss of regenerative potential seen in the advanced stages of the dystrophic process, when muscle tissue is progressively replaced with fibrotic connective and adipose tissue. The factors responsible for the accumulation of fibrotic tissue in dystrophic muscles remain to be established but likely involve different cell types, including macrophages, FAPs, and T cells. It has been shown that TGF-b2, induced in response to elevated canonical Wnt signaling, induces a fibrogenic program in muscle stem cells from dystrophic mice; however, it was not determined whether immune cells are involved in this process [44] . The ablation of osteopontin, a glycoprotein secreted by a wide variety of tissues, causes an M1-to-M2 switch and increased Foxp3 expression in mdx mice, presumably reflecting increased Treg-cell infiltration, and this is correlated with reduced muscle fibrosis, reduced TGF-b, and increased muscle regeneration [45, 46] . ATP released by necrotic muscle fibers and by inflammatory cells inhibits Treg cells through the activation of purinergic P2X receptors [47] and blockade of the extracellular ATP/P2X purinergic signaling pathway in dystrophic mdx mice leads to an increase in Treg cells while reducing the inflammatory response and delaying the progression of the dystrophic phenotype [48] . The P2X7 purinergic receptor appears to be especially important in this respect, as genetic ablation of the P2rx7 gene in mdx mice, or P2RX7 antagonist administration, leads to improved muscle structure and function, with reduction of inflammation and fibrosis, and increased muscle strength and endurance [49] .
Dysfunction of Treg cells has been described in idiopathic inflammatory myopathies, such as polymyositis and dermatomyositis [50, 51] . Although skeletal muscle is spared from the inflammatory autoimmune response in scurfy mice, like in humans with IPEX syndrome, a severe myositis is induced in these mice when the Foxp3 mutation is combined with abnormal exposure to muscle antigens, such as myosin, and Treg-cell supplementation can effectively suppress this autoimmune inflammatory response [52] . Another study showed that experimental autoimmune myositis, induced using muscle myosin emulsified in Freund's adjuvant, is more severe in mice that were depleted of Treg cells, while injection of in vitro expanded polyclonal Treg cells at the time of immunization significantly improved the disease [53] . Based on the mouse models, one might consider Treg cell-based therapies for human polymyositis/dermatomyositis, using approaches previously suggested for autoimmune rheumatic diseases [54] and currently tested in clinical trials for other autoimmune diseases.
Conclusions
The demonstration that Treg cells accumulate in injured muscle and promote muscle regeneration Muscle regeneration in aged mice is improved in heterochronic parabiosis (aged mice parabiotically linked to young mice) compared to isochronic parabiosis (agedaged). The current interpretation is that serum factors from the young partner are responsible for restoring the regenerative potential of the aged muscle. An alternative, though not mutually exclusive, interpretation is that migrating 'young' Treg cells contribute to improve muscle regeneration. Drawings modified from [56] .
supports the notion that immune mechanisms have a central role in tissue repair. The current view is that macrophages and satellite cells are the major players in muscle regeneration, but several new findings reveal the existence of a more complex network of inflammatory and immune cells, cytokines, and growth factors affecting the proliferation and differentiation of muscle stem cells. In addition to macrophages, mostly derived from blood monocytes, it is now clear that other circulating cells, including eosinophils and Tregs, infiltrate the injured muscle and interact with local interstitial cells, like the FAPs. IL-33 released by FAPs-like cells can induce Treg accumulation in injured muscle; however, it is not clear whether other alarmins released by damaged tissue may be involved and whether the FAPs-like cells are identical to the previously described FAPs. Other open issues concern the mechanisms involved in the differentiation and clonal expansion of infiltrating Tregs, which acquire unique properties of 'muscle Tregs', and the changes that Tregs undergo with aging.
The identification of novel approaches to stimulate muscle regeneration is crucial to combat muscle wasting in neuromuscular diseases, such as muscular dystrophy, and has a wider application to a variety of pathological conditions, including age-dependent sarcopenia, i.e., the loss of muscle mass and force that accompanies the aging process. Satellite cells, the muscle stem cells responsible for muscle regeneration, are reduced in number and function in dystrophic and aged muscle; however, the relative role of intrinsic and extrinsic factors responsible for stem cell incapacitation remains to be established. The recognition that immunological mechanisms are not only essential in the response to pathogenic microbes and tumor cells but also may have a wider homeostatic role in tissue repair opens new perspectives in this field. In particular, the identification of Treg cells as a new major player in muscle repair suggests potential targets for interventions aimed at boosting muscle growth in chronic muscle disease and during aging.
